Research Outputs
Found 44 results
- Publications · Journal ArticleJCR Q1Scopus Q1Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI rationale and design of the TAILORED-CHIP trial
Park, HanbitKang, Do-YoonAhn, Jung-MinYun, Sung-CheolPark, Kyoung-HaJang, Jae-Sikand 21 more
- Publications · Journal ArticleJCR Q1Scopus Q1Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial
Heo, JeongLiang, Ja-DerKim, Chang WonWoo, Hyung-youngShih, I-LunYoo, So Youngand 5 more
- Publications · Journal ArticleScopus Q2Clinical Factors Associated With Dose Escalation of Solifenacin for the Treatment of Overactive Bladder in Real Life Practice
전지연송미호Han, ji yen나세리홍범식and 1 more
- Publications · Journal ArticleJCR Q1Scopus Q1Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas
Song, Y.Yoon, D. H.Yang, H.Cao, J.Ji, D.Shin, Ho-Jinand 11 more
- Publications · Journal ArticleJCR Q3Scopus Q2KCI Q2Prasugrel-based De-Escalation of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Patients with STEMI
Ki, You-JeongLee, Bong KiPark, Kyung WooBae, Jang-WhanHwang, DoyeonCha, Kwang-sooand 16 more
- Publications · Journal ArticleJCR Q1Scopus Q1Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial
Lee, Kyu-SunPark, Keun-HoPark, Kyung WooRha, Seung-WoonHwang, DoyeonChun, Kookjinand 16 more
- Publications · Journal ArticleJCR Q1Scopus Q1Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS Trial
Hwang, DoyeonLim, Young-HyoPark, Kyung WooChun, KookjinHan, Jung-Kyuand 15 more
- Publications · OtherJCR Q3Scopus Q2KCI Q2Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How
Park, Jin-supJeong, Young-Hoon
- Publications · Journal ArticleJCR Q1Scopus Q1Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial
Jeong, Young-HoonOh, Ju-HyeonYoon, Hyuck-JunPark, YongwhiSuh, JonKim, Jeong SuKim, June-hongand 11 more
- Publications · Journal ArticleJCR Q2Tolerability and Pharmacokinetics of Avanafil, a Phosphodiesterase Type 5 Inhibitor: A Single- and Multiple-Dose, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Study in Healthy Korean Male Volunteers
Jung, JinahChoe, SangminCho, Sang HeonGhim, Jong-LyulHwang, Aekyungand 7 more
- Publications · Journal ArticleJCR Q1Scopus Q1Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial
Kim, Hyo-SooKang, JeehoonHwang, DoyeonHan, Jung-KyuYang, Han-MoChun, Kookjinand 8 more
- Publications · Journal ArticleJCR Q1Scopus Q1Deescalation From Ticagrelor to Clopidogrel for Myocardial Infarction With Chronic Kidney Disease: A Secondary Analysis of a Randomized Clinical Trial
Kim, Sang HyunLee, Kwan YongByeon, JaehoSa, Young KyoungHwang, Byung-HeeCha, Kwang-sooand 38 more
- Publications · Journal ArticleJCR Q2Scopus Q2Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia
Lee, Sang MinLee, Won SikShin, Ho-JinLee, Je-JungSohn, Sang Kyunand 18 more
- Publications · Journal ArticleScopus Q2KCI Q3Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancer
Yang, EunyeongShin, Young SeobJoo, Ji HyeonChoi, WonsikKim, Su Ssanand 3 more
- Publications · Journal ArticleJCR Q2Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib
Koh, YoungilKim, InhoYoon, Sung-SooKim, Byoung KookKim, Dae-YoungChung, Joo SeopShin, Ho-JinSanghyun KimKim, Chang-Seokand 13 more
- Publications · Journal ArticleGSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization
Koh, YoungilKim, Dae-YoungPark, Sung-HyoJung, Seung-HyunPark, EunkyungShin, Ho-JinChung, Joo Seopand 12 more
- Publications · Journal ArticleJCR Q1Scopus Q1APOE-guided lecanemab dosing dissociates ARIA-E from ARIA-H: The K-ROAD study
Kang, HeekyoungJang, HyeminAhn, JehyunNa, Duk L.Lee, Jae-HongKim, Eunjooand 17 more
- Publications · Journal ArticleJCR Q1Scopus Q1Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC
Lim, Ho YeongHeo, JeongPeguero, Julio A.Ryoo, Baek-YeolDecaens, Thomasand 6 more
- Publications · Journal ArticleJCR Q1Scopus Q1First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity
Zeh, Herbert J.Downs-Canner, StephanieMcCart, J AndreaGuo, Zong ShengRao, Uma N. M.Tae Ho Hwangand 13 more
- Publications · Journal ArticleJCR Q2Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
Sohn, Sang KyunOh, Suk JoongKim, Byung SooRyoo, Hun MoChung, Joo Seopand 25 more



Login
Home
Researcher Page
ORCID
ISNI